BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 8867671)

  • 1. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
    Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
    J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
    Lee AH; Hong JH; Seo YS
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.
    Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ
    J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1.
    Paludan SR; Malmgaard L; Ellermann-Eriksen S; Boscá L; Mogensen SC
    Eur Cytokine Netw; 2001; 12(2):297-308. PubMed ID: 11399519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.
    Gribaudo G; Ravaglia S; Gaboli M; Gariglio M; Cavallo R; Landolfo S
    Virology; 1995 Aug; 211(1):251-60. PubMed ID: 7645218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
    Grumont RJ; Richardson IB; Gaff C; Gerondakis S
    Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential induction of JE/MCP-1 in subclones from a murine macrophage cell line, RAW 264.7: role of kappaB-3 binding protein.
    Ueno M; Sonoda Y; Funakoshi M; Mukaida N; Nose K; Kasahara T
    Cytokine; 2000 Mar; 12(3):207-19. PubMed ID: 10704247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two factors, IRF1 and KBF1/NF-kappa B, cooperate during induction of MHC class I gene expression by interferon alpha beta or Newcastle disease virus.
    Ten RM; Blank V; Le Bail O; Kourilsky P; Israël A
    C R Acad Sci III; 1993; 316(5):496-501. PubMed ID: 8221233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p48/STAT-1alpha-containing complexes play a predominant role in induction of IFN-gamma-inducible protein, 10 kDa (IP-10) by IFN-gamma alone or in synergy with TNF-alpha.
    Majumder S; Zhou LZ; Chaturvedi P; Babcock G; Aras S; Ransohoff RM
    J Immunol; 1998 Nov; 161(9):4736-44. PubMed ID: 9794404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 response factor binds co-operatively at two adjacent sites in the promoter upstream region of the rat alpha 2-macroglobulin gene.
    Brechner T; Hocke G; Goel A; Fey GH
    Mol Biol Med; 1991 Apr; 8(2):267-85. PubMed ID: 1725449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts.
    Kouba DJ; Chung KY; Nishiyama T; Vindevoghel L; Kon A; Klement JF; Uitto J; Mauviel A
    J Immunol; 1999 Apr; 162(7):4226-34. PubMed ID: 10201951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages.
    Drouet C; Shakhov AN; Jongeneel CV
    J Immunol; 1991 Sep; 147(5):1694-700. PubMed ID: 1715367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y; Rohn WM; Benveniste EN
    J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells.
    Matsukura S; Stellato C; Plitt JR; Bickel C; Miura K; Georas SN; Casolaro V; Schleimer RP
    J Immunol; 1999 Dec; 163(12):6876-83. PubMed ID: 10586089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.
    Manzella L; Gualdi R; Perrotti D; Nicolaides NC; Girlando G; Giuffrida MA; Messina A; Calabretta B
    Exp Cell Res; 2000 Apr; 256(1):248-56. PubMed ID: 10739671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H; Mustafa A; Hiscott J; Lin R
    Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.